Association of Genetic Variations and Weight Loss Response to Naltrexone/Bupropion
Latest Information Update: 05 Apr 2024
At a glance
- Drugs Naltrexone/bupropion (Primary)
- Indications Obesity
- Focus Therapeutic Use
Most Recent Events
- 31 Mar 2024 Planned End Date changed from 1 Jun 2027 to 30 Jun 2027.
- 31 Mar 2024 Planned primary completion date changed from 1 Jun 2027 to 30 Jun 2027.
- 29 Jun 2023 New trial record